Parth Rao, PharmD, MS

Director of Lab Operations at Portal Innovations

Parth Rao, PharmD, MS has a diverse work experience in the pharmaceutical and biotech industry. Parth is currently serving as the Director of Lab Operations at Portal Innovations, LLC since January 2023. Prior to that, from December 2021 to January 2023, they worked as a Field Account Manager at Sartorius Stedim Biotech.

From 2018 to 2021, Parth worked at Novartis Gene Therapies, where they held two roles. Parth started as a Manufacturing Supervisor, leading a team in producing clinical and commercial material in compliance with regulatory standards. Parth successfully reduced deviations by 90% within a quarter. Later, they took on the role of Bioprocess Engineer - Team Lead, responsible for overseeing the manufacturing process of Zolgensma, a treatment for spinal muscular atrophy. Parth ensured quality standards and reviewed batch records to ensure compliance.

Parth's previous experience includes working at Adello Biologics, LLC from 2016 to 2018 as a Manufacturing Scientist, leading a team in manufacturing operations and ensuring compliance with cGMP. Parth also worked at Eurofins as a Business Development Manager (2015-2017) and at Intertek as a Key Account Manager in the Toys & Hardlines division (2010-2015). In these roles, they focused on establishing testing procedures, tracking new business opportunities, and maintaining relationships with clients.

Overall, Parth has demonstrated expertise in manufacturing operations, compliance with regulatory standards, and business development in the pharmaceutical and biotech industry.

Parth Rao, PharmD, MS completed their education at the University of Illinois Chicago, where they obtained a Doctor of Pharmacy (PharmD) degree in the field of Pharmacy. Parth'seducation at the University of Illinois Chicago ended in 2021. Prior to that, there is no provided information about their education history.

Links

Previous companies

Eurofins logo

Timeline

  • Director of Lab Operations

    January, 2023 - present